Supplemental material
Journal of Medical Economics
Volume 27, 2024 - Issue 1
Oncology
Real world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation type
Pratyusha Vadagama Janssen Scientific Affairs, LLC, Horsham, PA, USACorrespondence[email protected]
https://orcid.org/0009-0008-2037-6378
https://orcid.org/0009-0008-2037-6378, Dexter Watersa Janssen Scientific Affairs, LLC, Horsham, PA, USAhttps://orcid.org/0000-0002-9217-976X
https://orcid.org/0000-0002-9217-976X, Inyoung Leeb IQVIA, Durham, NC, USAhttps://orcid.org/0000-0001-5436-2013
https://orcid.org/0000-0001-5436-2013, Justin Chenb IQVIA, Durham, NC, USAhttps://orcid.org/0009-0002-7960-9697
https://orcid.org/0009-0002-7960-9697, Dajun Tianb IQVIA, Durham, NC, USAhttps://orcid.org/0000-0001-8147-8564
https://orcid.org/0000-0001-8147-8564, Aimee M. Nearb IQVIA, Durham, NC, USAhttps://orcid.org/0000-0001-9423-8244
https://orcid.org/0000-0001-9423-8244, & Julie Vanderpoela Janssen Scientific Affairs, LLC, Horsham, PA, USAhttps://orcid.org/0000-0001-5055-6216
https://orcid.org/0000-0001-5055-6216 show all